(redirected from citrated plasma)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for plasma

the colorless watery fluid of the blood and lymph that contains no cells, but in which the blood cells (erythrocytes, leukocytes, and thrombocytes) are suspended

a green slightly translucent variety of chalcedony used as a gemstone

Related Words

(physical chemistry) a fourth state of matter distinct from solid or liquid or gas and present in stars and fusion reactors

References in periodicals archive ?
HemosIL FDP assay is an automated, latex-enhanced immunoturbidimetric assay for the quantitative determination of FDP in human citrated plasma.
062-962 pmol/L) in assay buffer or uPAR-depleted citrated plasma to evaluate the limit of detection and the LOQ.
4) This test measures the rate of fibrin clot formation after the addition of reptilase to citrated plasma.
After correction for sample dilution by the added anticoagulants, the mean (SD) FSTL1 concentrations obtained for citrated plasma [82% (19%); n = 10; P= 0.
In this experiment, we compared the polyclonal anti-GDF15 antibody and a newly available monoclonal anti-GDF15 antibody with respect to antigen capture in serum and citrated plasma (containing 10 mmol/L trisodium citrate) to further evaluate the specificity of the assay.
This new generation rapid, automated, latex-enhanced immunoassay for the quantitative determination of D-Dimer in human citrated plasma on the ACL TOP(TM) Hemostasis Testing System, aids in the diagnosis of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and pulmonary embolism (PE)].
HemosIL D-Dimer is an automated latex enhanced immunoassay for the quantitative determination of D-Dimer in human citrated plasma on IL Coagulation Systems as an aid in the diagnosis of venous thromboembolism (VTE) [deep venous thrombosis (DVT) and pulmonary embolism (PE)].
Intraassay imprecision (CV) was determined by measuring samples from 4 different citrated plasma pools 21 times in one run, and interassay imprecision (CV) was evaluated from the analysis of one sample from each plasma pool at 6 days.
The dual-channel BFT(TM) II analyzer performs routine coagulation tests, such as prothrombin time (PT), activated partial thromboplastin time (aPTT) and fibrinogen, using citrated plasma.
We show here close agreement of D-dimer concentrations determined from citrated plasma samples and serum.
Each antibody combination was used to measure the tPA/PAI-1 complex in seven citrated plasma samples containing increased PAI-1 activity [range, 25 000-115 000 IU/L (25-115 IU/mL); mean [+ or -] SD, 68 000 [+ or -] 34 000 IU/L (68 [+ or -] 34 IU/mL)], before and after addition of an excess of active tPA.
The values for S100B from citrated plasma became equivalent to serum values when 5 mmol/L [Ca.